celiac and semaglutide GLP-1 RAs Reduce Anemia Risk in Patients with Disease GLP-1-based meds linked to fewer

Not sure where your skin falls on that spectrum

This is precisely why a medically supervised program starts you on a very low dose and increases it gradually over several weeks

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

Applied and Environmental Microbiology, 72 , 17291738

(136) developed an ROS-responsive berberine polymer micelle based on the abnormal elevation of ROS in RA-FLSs, which could increase the uptake of berberine by RA-FLSs, inhibit synovial tissue proliferation, and attenuate the inflammatory response by recognizing ROS and mitochondrial superoxide